Amiodarone-associated optic neuropathy: a critical review.

@article{Passman2012AmiodaroneassociatedON,
  title={Amiodarone-associated optic neuropathy: a critical review.},
  author={Rod S. Passman and Charles L Bennett and Joseph M Purpura and Rashmi Kapur and Lenworth N. Johnson and Dennis W. Raisch and Dennis P. West and Beatrice Edwards and Steven M. Belknap and Dustin B Liebling and Mathew J Fisher and Athena T. Samaras and Lisa-Gaye A Jones and Katrina-Marie E Tulas and June M Mckoy},
  journal={The American journal of medicine},
  year={2012},
  volume={125 5},
  pages={
          447-53
        }
}
Although amiodarone is the most commonly prescribed anti-arrhythmic drug, its use is limited by serious toxicities, including optic neuropathy. Current reports of amiodarone-associated optic neuropathy identified from the Food and Drug Administration's Adverse Event Reporting System and published case reports were reviewed. A total of 296 reports were identified: 214 from the Adverse Event Reporting System, 59 from published case reports, and 23 from adverse events reports for patients enrolled… CONTINUE READING
5
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-4 OF 4 CITATIONS

Amiodarone-Associated Optic Neuropathy: Clinical Review.

  • Neuro-ophthalmology
  • 2017
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Adverse reactions of Amiodarone

Ruben ML Colunga Biancatelli, Viviana Congedo, +3 authors Luigi Iuliano
  • Journal of geriatric cardiology : JGC
  • 2019